Feasibility of Better Living After Stroke Through Technology (BLAST)

April 9, 2021 updated by: Timothy J Wolf, University of Missouri-Columbia
The investigators propose to evaluate the feasibility of Better Living After Stroke through Technology (BLAST) to help stroke survivors and family members return back to their productive and meaningful lives by proactively 1) helping them set their activity goals using ACS, 2) assessing their behavioral/functional capabilities using FBP, 3) recognizing symptoms indicative potential secondary stroke risks, 4) engaging support from online/community resources, and 5) offering tailored self-management recommendations using evidence-based strategies on how to achieve their activity goals and avoid secondary stroke based on their capabilities, stroke-related symptoms and available social resources.

Study Overview

Status

Terminated

Conditions

Intervention / Treatment

Detailed Description

Stroke, which is the leading cause of disability, cognitive impairment and death in the US, imposes significant financial and personal burden. Although the residual effects of stroke affect many aspects of life, many aspects are not addressed by traditional rehabilitation treatments. In particular, persons with mild stroke, typically defined as a stroke with no or slight motor impairment and a high level of independence in basic activities of daily living, often experience emotional problems, subtle but significant cognitive impairment and decreased participation in productive, social and leisure activity. Despite these problems, persons with mild stroke are typically discharged to home without further referral to health or rehabilitation services other than follow-up with primary care physicians.

This application is in response to RFA PA-11-335 (Lab to Marketplace: Tools for Biomedical and Behavioral Research), a special 2-year Phase I SBIR program to accelerate the translation of behavioral research from academic to the marketplace. The project is based on the extensive research that developed and tested reliable and valid measures of activity participation (Activity Card Sort, or ACS) and cognitive skills supporting performance of simple and complex functional tasks (Functional Behavior Profile, or FBP). These measures have been used to guide treatments to help persons with mild cognitive impairment and their families support functional independence. These measures and the results of other studies will be used to build a dynamic online self-management tool designed to help persons with mild stroke develop individualized strategies that will support optimal recovery.

The investigators propose to evaluate the feasibility of Better Living After Stroke through Technology (BLAST) to help stroke survivors and family members return back to their productive and meaningful lives by proactively 1) helping them set their activity goals using ACS, 2) assessing their behavioral/functional capabilities using FBP, 3) recognizing symptoms indicative potential secondary stroke risks, 4) engaging support from online/community resources, and 5) offering tailored self-management recommendations using evidence-based strategies on how to achieve their activity goals and avoid secondary stroke based on their capabilities, stroke-related symptoms and available social resources.

Stroke survivors and family using the BLAST system are expected to have 1) better life satisfaction as measured by the Overall Recovery item of the Stroke Impact Scale; 2) increased activity as measured by Activity Card Sort; 3) better problem-solving and task performance as measured by Functional Behavior Profile; and 4) fewer caregiver concerns as measured by the Stroke Caregiver Needs Scale.

Specific Aims: 1) to evaluate the acceptability of BLAST ; and 2) to evaluate the preliminary effect of BLAST on self-efficacy, participation, and community reintegration.

Study Type

Interventional

Enrollment (Actual)

7

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Missouri
      • Columbia, Missouri, United States, 65211
        • University of Missouri: Department of Occupational Therapy

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

55 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • 55 years of age and older
  • diagnosis of mild to moderate ischemic stroke (NIHSS <16)
  • 3 months to 5 years post-stroke onset (of most recent stroke)
  • the availability of a willing caregiver or supportive individual throughout the intervention
  • access to a computer or tablet with internet access
  • discharged from the hospital to the community
  • able to read, write, and speak English fluently; and (8) community dwelling

Exclusion Criteria:

  • history of functional impairment prior to the index stroke as self-reported on the Telephone Screening Form
  • current diagnosis of a severe psychiatric disorder
  • current drug/alcohol abuse
  • terminal illness
  • Montreal Cognitive Assessment score of less than 23
  • direct verbal cue required for EFPTe test
  • severe depressive symptoms as indicated on the Patient Health Questionnaire (PHQ-9 score greater than 19)
  • any thoughts of harming themselves or others as indicated on question #9 of the PHQ-9.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: NA
  • Interventional Model: SINGLE_GROUP
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: BLAST
All participants in this study will be assigned to this group to participate in the BLAST intervention. The intervention will be a self-guided web-based platform using a self-management model to help support better engagement in everyday life activity
12-week self-guided intervention using a web-based platform

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Participation Strategies Self-Efficacy Scale (change)
Time Frame: Change from baseline score at 12 weeks (post-intervention)
35-item scale designed to assess self-efficacy in using participation strategies following a stroke using six subscales: (1) managing home participation, (2) staying organized, (3) planning and managing community participation, (4) managing work/productivity, (5) managing communication, and (6) advocating for resources, where higher scores equate to more self-efficacy.
Change from baseline score at 12 weeks (post-intervention)
Activity Card Sort (change)
Time Frame: Change from baseline score at 12 weeks (post-intervention)
records the activity participation and engagement of adults in instrumental, leisure and social activities currently and prior to a health event. Possible scores 0 - 32 where 32 indicates the most activity.
Change from baseline score at 12 weeks (post-intervention)
Patient-Reported Outcomes Measurement Information System (PROMIS)- 29 (change)
Time Frame: Change from baseline score at 12 weeks (post-intervention)
generic health-related quality of life survey, assesses each of the 7 PROMIS domains: depression; anxiety; physical function; pain interference; fatigue; sleep disturbance; and ability to participate in social roles and activities. Scale of 1 - 5, where 1 = poorest quality of life and 5 = best quality of life.
Change from baseline score at 12 weeks (post-intervention)
Stroke Impact Scale (change)
Time Frame: Change from baseline score at 12 weeks (post-intervention)
stroke-specific, self-report, health status measure. It was designed to assess multidimensional stroke outcomes, including strength, hand function Activities of Daily Living / Instrumental Activities of Daily Living, mobility, communication, emotion, memory and thinking, and participation. Total possible score = 59 - 295 where 295 = the least impact of stroke.
Change from baseline score at 12 weeks (post-intervention)
After Scenario Questionnaire
Time Frame: 12-weeks after baseline assessment (post-intervention)
assessment of acceptability of the intervention. Scale of 1 - 7 where 1 = lowest acceptability and 7 = most acceptability.
12-weeks after baseline assessment (post-intervention)
Post Study System Usability Questionnaire
Time Frame: 12-weeks after baseline assessment (post-intervention)
assessment of participant satisfaction and evaluation of usability of the web-based platform. Scale of 1 - 7 where 1 = least satisfaction and 7 = most satisfaction.
12-weeks after baseline assessment (post-intervention)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patient Health Questionnaire (PHQ-9) (change)
Time Frame: Change from baseline score at 12 weeks (post-intervention)
9-item depression scale. Total possible score = 0 - 27 where 0 = no depression and 27 = severe depression.
Change from baseline score at 12 weeks (post-intervention)
Executive Function Performance Test- Enhanced (EFPTe) (change)
Time Frame: Change from baseline score at 12 weeks (post-intervention)
assessment tool used to measure executive functioning in daily life activities. Scale of 0 - 5 where 0 = most independence and 5 = least independence.
Change from baseline score at 12 weeks (post-intervention)
Functional Behavior Profile (change)
Time Frame: Change from baseline score at 12 weeks (post-intervention)
clinical assessment measure that provides caregivers with a method of describing the impaired person's capabilities in performing tasks, social interactions, and problem-solving following a stroke. Total possible score = 0 - 108 where 108 = most functional behavior.
Change from baseline score at 12 weeks (post-intervention)
Reintegration to Normal Living Index/Scale (change)
Time Frame: Change from baseline score at 12 weeks (post-intervention)
assessment of the degree to which individuals who have experienced traumatic or incapacitating illness achieve reintegration into normal social activities (e.g. recreation, movement in the community, and interaction in family or other relationships). Total possible score = 0 - 100 where 100 = total reintegration.
Change from baseline score at 12 weeks (post-intervention)
Lawton Instrumental Activities of Daily Life Scale (change)
Time Frame: Change from baseline score at 12 weeks (post-intervention)
assessment for identifying how a person is functioning at the present time and for identifying improvement or deterioration over time in IADL activities. Total possible score = 0 - 8 where 8 = high function.
Change from baseline score at 12 weeks (post-intervention)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Timothy Wolf, OTD, PhD, University of Missouri-Columbia

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

April 25, 2019

Primary Completion (ACTUAL)

May 18, 2020

Study Completion (ACTUAL)

May 18, 2020

Study Registration Dates

First Submitted

April 25, 2019

First Submitted That Met QC Criteria

May 1, 2019

First Posted (ACTUAL)

May 2, 2019

Study Record Updates

Last Update Posted (ACTUAL)

April 14, 2021

Last Update Submitted That Met QC Criteria

April 9, 2021

Last Verified

April 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stroke

Clinical Trials on BLAST

3
Subscribe